Colin Cremault serves as Research Analyst for the firm’s Advanced Technology Practice. Leveraging his background in the life sciences, Colin’s role heavily revolves around supporting the firm’s for-profit biotechnology clients in achieving their research and development goals. This includes proposal development, strategic intelligence, policy communications, and congressional engagement. His focus lies primarily on NIH, ARPA-H, FDA, and CDC grants, but also extends to biotechnology research funded by the Department of Defense.
Prior to joining McAllister & Quinn in the fall of 2024, Colin attended George Washington University where he earned a Bachelor of Science in Psychological and Brain Sciences. While pursuing his degree at GWU, Colin worked as a research assistant in a sensation and perception laboratory researching how humans make judgements of distance in two-dimensional space. In this role, Colin was responsible for participant briefs and debriefs, data collection, and the administration of the various experimental protocols.